Amphastar Pharmaceuticals financial statements

앰퍼스타 파머슈티컬스NASDAQ:AMPH · Nasdaq · Healthcare
$25.37-0.24%
2026-10-05 close

Amphastar Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $732M. 2024 operating profit was $205M.

Reported results

Amphastar Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q